                               SEQUENCE LISTING

<110> THE CLEVELAND CLINIC FOUNDATION
 
<120> RESISTANCE TO ANDROGEN DEPRIVATION THERAPY IN CANCER THERAPY

<130> CCF-022549 WO ORD

<140>
<141>

<150> 61/846,344
<151> 2013-07-15

<160> 27    

<170> PatentIn version 3.5

<210> 1
<211> 37
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
ggaccggcac aaggagaacc tgaagtccaa gactcag                                37


<210> 2
<211> 37
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
ctgagtcttg gacttcaggt tctccttgtg ccggtcc                                37


<210> 3
<211> 27
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 3
tccgcggccg cggagtgatt cctgcta                                           27


<210> 4
<211> 27
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 4
aagacgcgtg agctctagta gtcaaaa                                           27


<210> 5
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 5
atgtggaggg aggtgtgagt                                                   20


<210> 6
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 6
acggagatgg gtctcttcca                                                   20


<210> 7
<211> 30
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 7
actgaattcc aggccaattt acacctatcg                                        30


<210> 8
<211> 31
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 8
actctcgagt caaactatgt gaaggaatgg a                                      31


<210> 9
<211> 97
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 9
tgctgttgac agtgagcgac ctcatacaga aagtgacaag tagtgaagcc acagatgtac       60

ttgtcacttt ctgtatgagg ctgcctactg cctcgga                                97


<210> 10
<211> 97
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 10
tgctgttgac agtgagcgaa gaggaaagac catgtggttt tagtgaagcc acagatgtaa       60

aaccacatgg tctttcctct gtgcctactg cctcgga                                97


<210> 11
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 11
ccatgtggtt tgctgttacc aa                                                22


<210> 12
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 12
tcaaaacgac cctcaagtta aaaga                                             25


<210> 13
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 13
gcatgggatg gggatgaagt aag                                               23


<210> 14
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 14
catcaaatct gagggttgtc tgga                                              24


<210> 15
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 15
ccatttgcag gatctgtctg                                                   20


<210> 16
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 16
ggatgtgtct tggggagcaa                                                   20


<210> 17
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 17
cgagggcacc tggaaaac                                                     18


<210> 18
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 18
cacattcccc cggatatga                                                    19


<210> 19
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 19
agaaggctgg ggctcatttg                                                   20


<210> 20
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 20
aggggccatc cacagtcttc                                                   20


<210> 21
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6xHis tag

<400> 21
His His His His His His 
1               5       


<210> 22
<211> 33
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 22
gatgagccat tcctgaggag agcctgccag gac                                    33


<210> 23
<211> 33
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 23
gtcctggcag gctctcctca ggaatggctc atc                                    33


<210> 24
<211> 33
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 24
gaggaagcca agcagagaac ggtggagtgg gtt                                    33


<210> 25
<211> 33
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 25
aacccactcc accgttctct gcttggcttc ctc                                    33


<210> 26
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 26
Leu Thr Val Leu Glu Gly Asp Ile Leu Asp Glu Pro Phe Leu Lys Arg 
1               5                   10                  15      


<210> 27
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Gln Lys Thr Val Glu Trp Val Gly Ser Lys Val Asp Arg 
1               5                   10              


